Trending Now
Search for your favorite author
Steve
Amy
Natalie
Tommaso
this month featured authors
or click on the right to get a complete list of authors
Continue to the categorySubscribe! Newsletter This week's featured author
One article every two weeks from pharma experts
Editor´s Pick
Israel’s Healthy.io raises $60 million, gets FDA ok for urine test
Israel's Healthy.io said on Thursday it raised $60 million in funding and received clearance from the U.S. Food and Drug Administration for its smartphone-based urine albumin test to aid in diagnosing chronic kidney disease.
U.S. judge approves novel framework for opioid settlement talks
A federal judge on Wednesday approved the substance of a proposal by lawyers representing cities and counties suing drug companies over the U.S. opioid epidemic that would bring every state and municipality in the country into their settlement talks.
Purdue Pharma reaches tentative opioid settlement with some: sources
OxyContin maker Purdue Pharma LP reached a tentative agreement with some plaintiffs to resolve litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing the settlement offer in bankruptcy proceedings as soon as next week, people familiar with the matter said.
Purdue OxyContin settlement would rank among largest in pharma history
OxyContin maker Purdue Pharma LP has reached a tentative multibillion-dollar agreement with some plaintiffs aimed at settling thousands of lawsuits over its alleged role in the U.S. opioid crisis, Reuters reported on Wednesday, citing people familiar with the matter.
Sanofi to pay Lexicon $260 million for terminated partnership
Lexicon Pharmaceuticals Inc said on Tuesday France's Sanofi SA will pay the drugmaker $260 million for the termination of their partnership to develop diabetes drug Zynquista.
Female pediatricians paid 76 cents for every $1 paid to men
(Reuters Health) - Women in pediatrics still earn less than men even with similar levels of experience and even after accounting for the disproportionate amount of time they devote to unpaid work at home, two new studies suggest.
Teens with illnesses want role in decision-making
(Reuters Health) - Teens with chronic illnesses would like to have a say in decisions such as switching to a new medicine, but they often feel left out of the conversation, a small study suggests.
Juul warned by FDA over marketing practices
The U.S. Food and Drug Administration warned Juul Labs Inc on Monday for marketing its e-cigarettes as safer than traditional cigarettes, the latest move by the agency to curb the use of vaping devices that have become extremely popular among teens.
AstraZeneca’s Imfinzi prolongs survival in aggressive lung cancer
AstraZeneca's cancer treatment Imfinzi has been shown to prolong survival in a particularly aggressive type of lung cancer by close to three months, as the British drugmaker holds its ground in a crowded field against rival immunotherapy drugs.
Novartis CEO promises to speed data integrity disclosures
Novartis Chief Executive Vas Narasimhan, facing an uproar over data manipulation involving $2.1 million gene therapy Zolgensma, pledged on Monday to tell regulators quickly if credible questions emerge in future over data integrity.
Neurotrope shares crash after Alzheimer’s drug fails in trial
Drug developer Neurotrope Inc's shares tumbled nearly 80% on Monday after the company said its experimental treatment for Alzheimer's disease did not meet the main goal of a mid-stage study.
Slovakian biotech firm signals tentative Alzheimer’s drug hope
An Alzheimer's vaccine developed by a privately held Slovakian biotech firm showed early signs of efficacy in a mid-stage trial, a rare step forward in the fight against the brain-wasting disease, the company said on Monday.
Lilly’s targeted RET drug shrinks tumors in lung cancer trial
Eli Lilly and Co's LOXO-292, a experimental cancer drug the company acquired in January as part of its $8 billion takeover of Loxo Oncology, shrank tumors in nearly 70% of advanced lung cancer patients whose tumors carried specific abnormalities in the RET gene.
Look Who’s On the Move!
Research and Development
Regulatory Affairs
Industry News